Answers are grounded in this paper and cite their sources.
Ecosystem map and evidence-informed portfolio of digital tools and services supporting personalised cancer medicine across diagnosis and treatment, molecular tumour boards, patients and families, research, and current clinical practice. This deliverable is organised into five chapters, each dedicated to a specific category of tools: Chapter 1: Review on AI Diagnostics and Treatment, Chapter 2: Review on MTB Platforms, Chapter 3: Review on Patients and Families, Chapter 4: Review on Research, Chapter 5: Survey on Current Digital Tool Use in Clinical Practice.
No takes yet. Share an insight, caveat, or question.
Moreira et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: